$123 Million is the total value of Daniel Devine & Co's 51 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | Berkshire Hathaway Inc-Cl B | $3,132,000 | +0.6% | 15,700 | 0.0% | 2.54% | +13.0% | |
| FDX | FedEx Corporation | $2,043,000 | -3.8% | 8,510 | 0.0% | 1.66% | +7.9% | |
| UNH | UnitedHealth Group Inc. | $1,919,000 | -2.9% | 8,965 | 0.0% | 1.56% | +9.1% | |
| BLK | Blackrock Inc | $1,820,000 | +5.4% | 3,360 | 0.0% | 1.48% | +18.3% | |
| NVS | Novartis ADRspon adr | $1,750,000 | -3.7% | 21,650 | 0.0% | 1.42% | +8.1% | |
| RDSB | Royal Dutch Shell PLC-ADR B | $1,456,000 | -4.1% | 22,225 | 0.0% | 1.18% | +7.7% | |
| AZN | AstraZeneca PLC - Spons ADRspon adr | $1,308,000 | +0.8% | 37,400 | 0.0% | 1.06% | +13.1% | |
| BX | Blackstone Group LPltd | $1,204,000 | -0.2% | 37,670 | 0.0% | 0.98% | +12.2% | |
| CNBKA | Century Bancorp Cl A | $896,000 | +1.5% | 11,284 | 0.0% | 0.73% | +13.9% | |
| APD | Air Products & Chemicals | $837,000 | -3.1% | 5,263 | 0.0% | 0.68% | +8.8% | |
| MO | Altria Group Inc. | $536,000 | -12.7% | 8,600 | 0.0% | 0.44% | -2.0% | |
| NTG | Tortoise MLP Fund | $519,000 | -9.1% | 32,498 | 0.0% | 0.42% | +2.2% | |
| NSRGY | Nestle SA ADRspon adr | $435,000 | -8.0% | 5,500 | 0.0% | 0.35% | +3.2% | |
| MA | Mastercard Inc - Cl A | $427,000 | +15.7% | 2,435 | 0.0% | 0.35% | +30.0% | |
| IOO | IShares Global 100etf | $404,000 | -1.5% | 4,425 | 0.0% | 0.33% | +10.4% | |
| CSX | CSX Corp | $360,000 | +1.1% | 6,464 | 0.0% | 0.29% | +13.2% | |
| PG | Procter & Gamble | $281,000 | -13.5% | 3,542 | 0.0% | 0.23% | -3.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-04-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 | 15 | Q2 2018 | 24.0% |
| Powershares QQQ Trust | 15 | Q2 2018 | 13.0% |
| SPDR S&P Midcap 400 | 15 | Q2 2018 | 12.1% |
| Apple Inc | 15 | Q2 2018 | 6.0% |
| Johnson & Johnson | 15 | Q2 2018 | 4.0% |
| IShares MSCI Emerg Mkt | 15 | Q2 2018 | 2.6% |
| Chevron Corporation | 15 | Q2 2018 | 2.6% |
| Visa Inc Cl A | 15 | Q2 2018 | 2.1% |
| Abbvie Inc | 15 | Q2 2018 | 2.3% |
| Select Sector SPDR Industrial | 15 | Q2 2018 | 3.0% |
View Daniel Devine & Co's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-07-18 |
| 13F-HR | 2018-04-25 |
| 13F-HR | 2018-01-24 |
| 13F-HR | 2017-11-17 |
| 13F-HR | 2017-07-20 |
| 13F-HR | 2017-04-27 |
| 13F-HR | 2017-01-19 |
| 13F-HR | 2016-10-21 |
| 13F-HR | 2016-07-29 |
| 13F-HR | 2016-04-13 |
View Daniel Devine & Co's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.